XML 29 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
EARNINGS PER SHARE ("EPS")
9 Months Ended
Dec. 29, 2018
Earnings Per Share [Abstract]  
EARNINGS PER SHARE (EPS)
EARNINGS PER SHARE (“EPS”)

The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations.
 
Three Months Ended
 
Nine Months Ended
 (In thousands, except per share amounts)
December 29,
2018
 
December 30,
2017
 
December 29,
2018
 
December 30,
2017
Basic EPS
 
 
 
 
 
 
 
Net income (loss)
$
18,277

 
$
(6,547
)
 
$
34,184

 
$
33,692

Weighted average shares
51,401

 
53,090

 
51,708

 
52,717

Basic income (loss) per share
$
0.36

 
$
(0.12
)
 
$
0.66

 
$
0.64

Diluted EPS
 
 
 
 
 
 
 
Net income (loss)
$
18,277

 
$
(6,547
)
 
$
34,184

 
$
33,692

Basic weighted average shares
51,401

 
53,090

 
51,708

 
52,717

Net effect of common stock equivalents
1,421

 

 
1,476

 
568

Diluted weighted average shares
52,822

 
53,090

 
53,184

 
53,285

Diluted income (loss) per share
$
0.35

 
$
(0.12
)
 
$
0.64

 
$
0.63



Basic earnings per share is calculated using the Company's weighted-average outstanding common stock. Diluted earnings per share is calculated using its weighted-average outstanding common stock including the dilutive effect of stock awards as determined under the treasury stock method. For the three and nine months ended December 29, 2018, weighted average shares outstanding, assuming dilution, excludes the impact of 0.2 million and 0.1 million anti-dilutive shares, respectively. For the three months ended December 30, 2017, the Company recognized a net loss; therefore it excluded the impact of outstanding stock awards from the diluted loss per share calculation as its inclusion would have an anti-dilutive effect. For the nine months ended December 30, 2017, weighted average shares outstanding, assuming dilution, excludes the impact of 0.5 million anti-dilutive shares.

Share Repurchase Program

On February 6, 2018, the Company announced that its Board of Directors authorized the repurchase of up to $260 million of its outstanding common stock from time to time, based on market conditions, through March 30, 2019. As of December 29, 2018, the Company had utilized the full $260 million share repurchase authorization, which resulted in approximately 3.0 million total shares repurchased at an average price of $86.58 per share.

In May 2018, the Company completed a $100.0 million repurchase of its common stock pursuant to an accelerated share repurchase agreement ("ASR") entered into with Citibank N.A (“Citibank”) in February 2018. The total number of shares repurchased under the ASR was approximately 1.4 million at an average price per share upon final settlement of $72.51. In August 2018, the Company completed an additional $80.0 million repurchase of its common stock pursuant to an ASR entered into with Citibank in June 2018. The total number of shares repurchased under the ASR was approximately 0.9 million at an average price per share upon final settlement of $93.83. In December 2018, the Company repurchased the remaining $80.0 million of its common stock under the Company's share repurchase authorization pursuant to an ASR entered into with Citibank in November 2018. The total number of shares repurchased under the ASR was approximately 0.8 million at an average price per share upon final settlement of $103.74.